U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
7989179891Compare the Effects of Lercanidipine Hydrochloride Tablet (Zanidip®) and Felodipine Sustained-Release Tablet for HypertensionCompletedNo Results AvailableHypertensionDrug: Zanidip|Drug: Felodipine sustained-release tablethttps://ClinicalTrials.gov/show/NCT01520285
7989279892HPV Vaccine Effectiveness in Partially Vaccinated Girls in UgandaCompletedNo Results AvailableHPV16 Anitbody Levels Post Vaccination|HPV18 Antibody Levels Post Vaccinationhttps://ClinicalTrials.gov/show/NCT01520272
7989379893Initial Study of Gallbladder Cancer in ChileCompletedNo Results AvailableGallbaldder Cancerhttps://ClinicalTrials.gov/show/NCT01520259
7989479894Gene Expression in Samples From Patients With T-Cell Acute Lymphoblastic LeukemiaActive, not recruitingNo Results AvailableLeukemia|LymphomaGenetic: gene expression analysis|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT01520246
7989579895Gene Expression in Predicting Outcome in Samples From Patients With High-Risk NeuroblastomaActive, not recruitingNo Results AvailableNeuroblastomaGenetic: RNA analysis|Genetic: gene expression analysis|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT01520233
7989679896Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative NeoplasmsActive, not recruitingNo Results AvailableMyeloproliferative Neoplasms of|Polycythemia Vera|Essential Thrombocythemia|MyelofibrosisDrug: LY2784544https://ClinicalTrials.gov/show/NCT01520220
7989779897Mannitol - Potential Role in Hemodialysis Initiation for Reduction of Intra-dialytic HypotensionRecruitingNo Results AvailableIntra-dialytic HypotensionDrug: Mannitol (20%)|Drug: 0.9% salinehttps://ClinicalTrials.gov/show/NCT01520207
7989879898The Psychosocial and Economic Burden of Genital WartsNot yet recruitingNo Results AvailableFemale Genital Wartshttps://ClinicalTrials.gov/show/NCT01520194
7989979899Extended Open Challenge in Patients With a History of Drug Eruption Following Beta-lactam TreatmentRecruitingNo Results AvailableBeta-lactam AllergyDrug: Beta-lactam oral challengehttps://ClinicalTrials.gov/show/NCT01520181
7990079900Composix Kugel Mesh Recall Leaves Unresolved Problems of Patient ManagementSuspendedNo Results AvailableIncisional Herniahttps://ClinicalTrials.gov/show/NCT01520168
7990179901CArdiovascular Risk Assessment STudy in Lupus Erythemathodes (CASTLE)CompletedNo Results AvailableSystemic Lupus Erythematosushttps://ClinicalTrials.gov/show/NCT01520155
7990279902Safety, Tolerability and Pharmacodynamic Activity of JNJ-26528398 in Healthy Male ParticipantsCompletedNo Results AvailableHealthy ParticipantsDrug: JNJ-26528398|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01520142
7990379903Pilot Study of Interpersonal and Social Rhythm Therapy for Subthreshold BipolarCompletedNo Results AvailableBipolar Disorder NOSOther: Interpersonal and social rhythm therapyhttps://ClinicalTrials.gov/show/NCT01520129
7990479904Study of the Safety and Efficacy of ATS907 in Subjects With Primary Open Angle Glaucoma (POAG) and Ocular HypertensionActive, not recruitingNo Results AvailablePrimary Open Angle Glaucoma|Ocular HypertensionDrug: Stage 1 - ATS907 - Dose 1|Drug: Stage 1 - ATS907 - Dose 2|Drug: Stage 1 - ATS907 - Dose 3|Drug: Stage 1 - ATS907 - Dose 4|Drug: Stage 1 - Vehicle|Drug: Stage 2 - ATS907 - Dose A - to be selected based on Stage 1|Drug: Stage 2 - ATS907 - Dose B - to be selected based on Stage 1|Drug: Timoptichttps://ClinicalTrials.gov/show/NCT01520116
7990579905Study to Compare Vinorelbine In Combination With the mTOR Inhibitor Everolimus vs. Vinorelbin Monotherapy for Second-line Treatment in Advanced Breast CancerRecruitingNo Results AvailableHer2-negative Metastatic Breast Cancer|Her2-negative Locally Advanced Breast CancerDrug: Vinorebine, Everolimus|Drug: Vinorelbinehttps://ClinicalTrials.gov/show/NCT01520103
7990679906Egyptian Women Knowledge and Use of Different Contraceptive MethodsRecruitingNo Results AvailableContraceptionhttps://ClinicalTrials.gov/show/NCT01520090
7990779907Vytorin in the Treatment of Alopecia AreataCompletedNo Results AvailableAlopecia AreataDrug: vytorinhttps://ClinicalTrials.gov/show/NCT01520077
7990879908Post Market Registry Study of the AeriSeal SystemTerminatedNo Results AvailablePulmonary Emphysemahttps://ClinicalTrials.gov/show/NCT01520064
7990979909Mepolizumab Treatment for Rhinovirus-induced Asthma ExacerbationsRecruitingNo Results AvailableAsthma|Viral InfectionDrug: Mepolizumab|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01520051
7991079910Adjuvant Proton Therapy or IMRT for the Treatment of Bladder CancerCompletedNo Results AvailableUrothelial Carcinoma of the BladderRadiation: Proton therapy|Radiation: IMRThttps://ClinicalTrials.gov/show/NCT01520038
7991179911Multi-modality Imaging of Ischemia With 18F-FDG PET and CTAActive, not recruitingNo Results AvailableMyocardial IschemiaRadiation: PET MPI imaging with 18F-Fluorodeoxyglucosehttps://ClinicalTrials.gov/show/NCT01520025
7991279912Food Effect on Pharmacokinetics of YH4808 in Healthy Male SubjectsCompletedNo Results AvailableHealthyDrug: YH4808 100 mg|Drug: YH4808 100 mg|Drug: YH4808 300 mg|Drug: YH4808 300 mg|Drug: YH4808 300 mghttps://ClinicalTrials.gov/show/NCT01520012
7991379913Colorectal Cancer Screening With Improved Shared Decision MakingActive, not recruitingNo Results AvailableColorectal Cancer Screening|Shared Decision MakingBehavioral: Shared Decision Making for Colorectal Cancer Screeninghttps://ClinicalTrials.gov/show/NCT01519999
7991479914The Effect of Fat on Vitamin D AbsorptionCompletedNo Results AvailableVitamin D DeficiencyDietary Supplement: Vitamin D3|Dietary Supplement: Placebohttps://ClinicalTrials.gov/show/NCT01519986
7991579915Optimization of SPECT ImagingTerminatedNo Results AvailableCoronary Artery DiseaseRadiation: SPECT/CT processed with Evolution for CardiacTM softwarehttps://ClinicalTrials.gov/show/NCT01519973
7991679916A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis BActive, not recruitingNo Results AvailableHepatitis B, ChronicDrug: peginterferon alfa-2a [Pegasys]|Drug: peginterferon alfa-2a [Pegasys]https://ClinicalTrials.gov/show/NCT01519960
7991779917A Study of The Effect of Altitude on Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) Dose Requirements in Patients With Chronic Renal Anemia in Pre-Dialysis or DialysisCompletedNo Results AvailableAnemia, Kidney Disease, ChronicDrug: methoxy polyethylene glycol-epoetin beta [Mircera]https://ClinicalTrials.gov/show/NCT01519947
7991879918A Retrospective Study to Evaluate the Effectiveness of the Ulthera SystemCompletedHas ResultsSkin Laxity|Wrinkleshttps://ClinicalTrials.gov/show/NCT01519934
7991979919A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B.CompletedNo Results AvailableHepatitis B, ChronicDrug: peginterferon alfa-2a [Pegasys]https://ClinicalTrials.gov/show/NCT01519921
7992079920Markers and Response to Cardiac Resynchronization TherapyActive, not recruitingNo Results AvailableHeart FailureDevice: CRT-D (Medtronic)https://ClinicalTrials.gov/show/NCT01519908

* Görseller ve İçerik tekif hakkına sahip olabilir